79%
Finnrick rating
#6 of 57 Semaglutide vendors
5 of 5 classifiable tests passed
natural 100% · customers 4.5★ (1)
methodology · Purity focus
Finnrick analysis · Semaglutide

Bulk Peptide Supply Semaglutide shows a low-concern purity-focus profile, with repeat identity passes, 99.66–99.95% purity, and fills from -3% to +12%. The caveat is batch documentation: several COAs lack lot IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Bulk Peptide Supply

Oklahoma entity records and court filings point to a named operator, while the storefronts use a mailbox-format address and split contact surface. The report traces COA gaps, payment-rail friction, and a dismissed impersonation suit without treating the sister site as automatically benign.

27 pages7 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
2
Semaglutideselected
$3.50
79%
5
3
Retatrutide
$5.25
77%
7
5
PT-141
$1.50
68%
2
6
BPC-157
-
58%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%29 Jun 2025: 72%3 Oct 2025: 74%14 Nov 2025: 76%9 Jan 2026: 78%18 Mar 2026: 80%25 Jul 2026: current 79%72%76%79%Jun 25Jul 26
Showing Semaglutide tests only
Bulk Peptide Supply Semaglutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
18 Mar 2026Pass
Tested
lab nameView COA
9 Jan 2026Pass
Tested
lab nameView COA
14 Nov 2025Pass
Tested
lab nameView COA
3 Oct 2025Pass
Tested
lab nameView COA
29 Jun 2025Pass
Tested
lab nameView COA

About Bulk Peptide Supply test results from Finnrick

Bulk Peptide Supply is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 27 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Bulk Peptide Supply peptides in this dataset are Semaglutide (5 tests) and Melanotan II (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 27 recent tests.

Corrections
No corrections.